WORLDWIDE, CERVICAL CANCER IS THE FOURTH MOST COMMON CANCER AMONG WOMEN AND A MAJOR CAUSE OF CANCER-RELATED DEATHS¹
Screening efficiency is proven and pre-cancers can be treated².
DATEXIM solutions raise diagnostic accuracy to a level never reached before,
reducing risks of missed cases and helping to save women’s lives.
¹ ² Sources
¹Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020; ARTICLES| VOLUME 8, ISSUE 2, PE191-E203, FEBRUARY 01, 2020. Published Online December 4, 2019 Link
www.thelancet.com – PDF Version
Our unique and innovative solution to revolutionize cervical cancer diagnostics
DATEXIM revolutionizes cervical cancer screening thanks to the first Artificial Intelligence CE marked solution.